FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079781353> ?p ?o ?g. }

• W2079781353 endingPage "W" @default.
• W2079781353 startingPage "W" @default.
• W2079781353 abstract "Letters20 April 2004Potentially Fatal Interaction between Diltiazem and StatinsPatrick Gladding, MBCHB, BHB, Helen Pilmore, MBCHB, FRACP, MD, and Colin Edwards, MBBCH(WITS), FCP(SA), FRACPPatrick Gladding, MBCHB, BHBFrom Auckland Healthcare Services Ltd., Grafton, and North Shore Hospital, Takapuna, Auckland, New Zealand.Search for more papers by this author, Helen Pilmore, MBCHB, FRACP, MDFrom Auckland Healthcare Services Ltd., Grafton, and North Shore Hospital, Takapuna, Auckland, New Zealand.Search for more papers by this author, and Colin Edwards, MBBCH(WITS), FCP(SA), FRACPFrom Auckland Healthcare Services Ltd., Grafton, and North Shore Hospital, Takapuna, Auckland, New Zealand.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-140-8-200404200-00037-w1 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Background: The interaction of diltiazem and statins, metabolized through cytochrome P450 3A4, leads to increased risk for rhabdomyolysis.Objective: To describe the interaction between diltiazem and simvastatin–atorvastatin and highlight its clinical significance.Case Reports: In case 1, a 59-year-old woman receiving long-term ambulatory peritoneal dialysis because of diabetes-induced renal failure presented with an ischemic toe. She was taking atorvastatin, 40 mg/d; aspirin; glyceryl trinitrate; isosorbide mononitrate; insulin; metoclopramide; vitamin D; omeprazole; calcium; and erythropoietin. She had been taking atorvastatin for more than 1 year.The patient developed angina, and diltiazem therapy was started; the daily dose was ...References1. Staffa JA, Chang J, Green L. Cerivastatin and reports of fatal rhabdomyolysis [Letter]. N Engl J Med. 2002;346:539-40. [PMID: 11844864] CrossrefMedlineGoogle Scholar2. Flint OP, Masters BA, Gregg RE, Durham SK. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture. Toxicol Appl Pharmacol. 1997;145:99-110. [PMID: 9221829] CrossrefMedlineGoogle Scholar3. Galper JB. Increased incidence of myositis in patients treated with high-dose simvastatin [Letter]. Am J Cardiol. 1998;81:259. [PMID: 9591920] MedlineGoogle Scholar4. Mousa O, Brater DC, Sunblad KJ, Hall SD. The interaction of diltiazem with simvastatin. Clin Pharmacol Ther. 2000;67:267-74. [PMID: 10741630] CrossrefMedlineGoogle Scholar5. Bae J, Jarcho JA, Denton MD, Magee CC. Statin specific toxicity in organ transplant recipients: case report and review of the literature. J Nephrol. 2002;15:317-9. [PMID: 12113605] MedlineGoogle Scholar6. Kanathur N, Mathai MG, Byrd RP, Fields CL, Roy TM. Simvastatin-diltiazem drug interaction resulting in rhabdomyolysis and hepatitis. Tenn Med. 2001;94:339-41. [PMID: 11550401] MedlineGoogle Scholar7. Peces R, Pobes A. Rhabdomyolysis associated with concurrent use of simvastatin and diltiazem [Letter]. Nephron. 2001;89:117-8. [PMID: 11528245] CrossrefMedlineGoogle Scholar8. Lewin JJ, Nappi JM, Taylor MH. Rhabdomyolysis with concurrent atorvastatin and diltiazem. Ann Pharmacother. 2002;36:1546-9. [PMID: 12243603] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Auckland Healthcare Services Ltd., Grafton, and North Shore Hospital, Takapuna, Auckland, New Zealand. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPharmacologic InteractionsPotential statin-drug interactions: prevalence and clinical significanceThe Effect of Atorvastatin on Liver Function among Patients with Coronary Heart Disease in Gaza StripSimvastatin-induced myopathy, the role of interaction with diltiazem and genetic predispositionEffects of Concomitant Therapy with Diltiazem on the Lipid Responses to Simvastatin in Chinese SubjectsPharmacologic Interactions in the CICUComputing with evidenceRhabdomyolysis Caused by a Potential Sitagliptin-Lovastatin InteractionPharmacokinetic Comparison of the Potential Over-the-Counter Statins Simvastatin, Lovastatin, Fluvastatin and PravastatinSafety Issues with Statin TherapyAdverse effects of statins 20 April 2004Volume 140, Issue 8Page: W-31KeywordsAttentionCase seriesCreatine kinaseDrugsEnzymesInsulinMedical dialysisRenal failureRhabdomyolysisStatins ePublished: 20 April 2004 Issue Published: 20 April 2004 Copyright & PermissionsCopyright © 2004 by American College of Physicians. All Rights Reserved.PDF downloadLoading ..." @default.
• W2079781353 created "2016-06-24" @default.
• W2079781353 creator A5002935320 @default.
• W2079781353 creator A5008615818 @default.
• W2079781353 creator A5079027471 @default.
• W2079781353 date "2004-04-20" @default.
• W2079781353 modified "2023-09-26" @default.
• W2079781353 title "Potentially Fatal Interaction between Diltiazem and Statins" @default.
• W2079781353 cites W140957336 @default.
• W2079781353 cites W1966929279 @default.
• W2079781353 cites W1995962199 @default.
• W2079781353 cites W2020690650 @default.
• W2079781353 cites W2123168834 @default.
• W2079781353 cites W2321631825 @default.
• W2079781353 cites W2416002450 @default.
• W2079781353 cites W64243007 @default.
• W2079781353 doi "https://doi.org/10.7326/0003-4819-140-8-200404200-00037-w1" @default.
• W2079781353 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15096363" @default.
• W2079781353 hasPublicationYear "2004" @default.
• W2079781353 type Work @default.
• W2079781353 sameAs 2079781353 @default.
• W2079781353 citedByCount "18" @default.
• W2079781353 countsByYear W20797813532013 @default.
• W2079781353 countsByYear W20797813532014 @default.
• W2079781353 countsByYear W20797813532015 @default.
• W2079781353 crossrefType "journal-article" @default.
• W2079781353 hasAuthorship W2079781353A5002935320 @default.
• W2079781353 hasAuthorship W2079781353A5008615818 @default.
• W2079781353 hasAuthorship W2079781353A5079027471 @default.
• W2079781353 hasConcept C126322002 @default.
• W2079781353 hasConcept C2776741139 @default.
• W2079781353 hasConcept C2777482532 @default.
• W2079781353 hasConcept C2778492647 @default.
• W2079781353 hasConcept C519063684 @default.
• W2079781353 hasConcept C71924100 @default.
• W2079781353 hasConceptScore W2079781353C126322002 @default.
• W2079781353 hasConceptScore W2079781353C2776741139 @default.
• W2079781353 hasConceptScore W2079781353C2777482532 @default.
• W2079781353 hasConceptScore W2079781353C2778492647 @default.
• W2079781353 hasConceptScore W2079781353C519063684 @default.
• W2079781353 hasConceptScore W2079781353C71924100 @default.
• W2079781353 hasIssue "8" @default.
• W2079781353 hasLocation W20797813531 @default.
• W2079781353 hasLocation W20797813532 @default.
• W2079781353 hasOpenAccess W2079781353 @default.
• W2079781353 hasPrimaryLocation W20797813531 @default.
• W2079781353 hasRelatedWork W1966593429 @default.
• W2079781353 hasRelatedWork W2019135295 @default.
• W2079781353 hasRelatedWork W2090588059 @default.
• W2079781353 hasRelatedWork W2093814069 @default.
• W2079781353 hasRelatedWork W2123168834 @default.
• W2079781353 hasRelatedWork W2370766369 @default.
• W2079781353 hasRelatedWork W2380319386 @default.
• W2079781353 hasRelatedWork W2575457464 @default.
• W2079781353 hasRelatedWork W3185990202 @default.
• W2079781353 hasRelatedWork W4205726400 @default.
• W2079781353 hasVolume "140" @default.
• W2079781353 isParatext "false" @default.
• W2079781353 isRetracted "false" @default.
• W2079781353 magId "2079781353" @default.
• W2079781353 workType "article" @default.